Amicus Therapeutics Inc. (NASDAQ:NASDAQ:FOLD) Q3 2022 Earnings Conference Call November 7, 2022 8:30 am ET Company Participants Bradley Campbell - President, Chief Executive Officer.
The drug losartan, normally used to treat high blood pressure or hypertension does not effect in slowing down the progression of Alzheimer s disease (AD) in people with the mild-to-moderate disease after 12 months of treatment, suggests new research by the University of Bristol.
According to new research by the University of Bristol the drug losartan, normally used to treat high blood pressure or hypertension does not effect in slowing down the progression of Alzheimer s disease (AD) in people with the mild-to-moderate disease after 12 months of treatment.